| 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
| 2024/11/18 | 22 : 06 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:HSDT | Helius Medical Technologies Inc |
| 2024/11/18 | 22 : 01 | GlobeNewswire Inc. | Helius Medical Technologies, Inc. Provides Updates on Efforts to Achieve Fair Market Access for its Portable Neuromodulation Stimulator (PoNS®) Device | NASDAQ:HSDT | Helius Medical Technologies Inc |
| 2024/11/18 | 22 : 00 | GlobeNewswire Inc. | Helius Medical Technologies, Inc. Announces Exploration of Strategic Alternatives | NASDAQ:HSDT | Helius Medical Technologies Inc |
| 2024/10/18 | 21 : 00 | GlobeNewswire Inc. | Helius Medical Technologies, Inc. to Present at the 2024 ThinkEquity Conference | NASDAQ:HSDT | Helius Medical Technologies Inc |
| 2024/10/15 | 06 : 00 | GlobeNewswire Inc. | Helius Medical Technologies, Inc. Announces Reimbursement Payment Determination Updates from CMS for its Portable Neuromodulation Stimulator (PoNS®) Controller and Mouthpiece | NASDAQ:HSDT | Helius Medical Technologies Inc |
| 2024/09/30 | 21 : 00 | GlobeNewswire Inc. | Helius Medical Technologies, Inc. Announces Positive Preliminary Results of the PoNSTEP Study | NASDAQ:HSDT | Helius Medical Technologies Inc |
| 2024/08/17 | 06 : 00 | GlobeNewswire Inc. | Helius Medical Technologies, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) | NASDAQ:HSDT | Helius Medical Technologies Inc |
| 2024/08/13 | 05 : 30 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:HSDT | Helius Medical Technologies Inc |
| 2024/08/13 | 05 : 15 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:HSDT | Helius Medical Technologies Inc |
| 2024/08/13 | 05 : 05 | GlobeNewswire Inc. | Helius Medical Technologies, Inc. Reports Second Quarter 2024 Financial Results | NASDAQ:HSDT | Helius Medical Technologies Inc |
| 2024/08/10 | 06 : 12 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:HSDT | Helius Medical Technologies Inc |
| 2024/08/10 | 06 : 12 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:HSDT | Helius Medical Technologies Inc |
| 2024/08/07 | 05 : 36 | GlobeNewswire Inc. | Helius Medical Technologies, Inc. to Release Second Quarter 2024 Financial Results on August 12, 2024 | NASDAQ:HSDT | Helius Medical Technologies Inc |
| 2024/07/25 | 05 : 16 | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee benefit plans | NASDAQ:HSDT | Helius Medical Technologies Inc |
| 2024/06/17 | 20 : 00 | GlobeNewswire Inc. | Helius Medical Technologies, Inc. Completes Site Participation Enrollment for its U.S. Registrational Program in Stroke | NASDAQ:HSDT | Helius Medical Technologies Inc |
| 2024/06/04 | 05 : 15 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:HSDT | Helius Medical Technologies Inc |
| 2024/06/01 | 05 : 30 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:HSDT | Helius Medical Technologies Inc |
| 2024/06/01 | 05 : 23 | Edgar (US Regulatory) | Form ARS - Annual Report to Security Holders | NASDAQ:HSDT | Helius Medical Technologies Inc |
| 2024/06/01 | 05 : 21 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements | NASDAQ:HSDT | Helius Medical Technologies Inc |
| 2024/05/31 | 05 : 15 | Edgar (US Regulatory) | Form SD - Specialized disclosure report | NASDAQ:HSDT | Helius Medical Technologies Inc |
| 2024/05/29 | 22 : 00 | GlobeNewswire Inc. | Helius Medical Technologies, Inc. Announces Third-Party Reimbursement for PoNS® from Major Insurance Carrier | NASDAQ:HSDT | Helius Medical Technologies Inc |
| 2024/05/20 | 22 : 00 | GlobeNewswire Inc. | Helius Medical Technologies, Inc. Announces PoNS® Is Now Available on the Veterans Affairs (VA) Federal Supply Schedule (FSS) and General Services Administration (GSA) Advantage Contracts | NASDAQ:HSDT | Helius Medical Technologies Inc |
| 2024/05/15 | 05 : 15 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial ownership by individuals | NASDAQ:HSDT | Helius Medical Technologies Inc |
| 2024/05/14 | 05 : 30 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:HSDT | Helius Medical Technologies Inc |
| 2024/05/14 | 05 : 15 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:HSDT | Helius Medical Technologies Inc |
| 2024/05/14 | 05 : 05 | GlobeNewswire Inc. | Helius Medical Technologies, Inc. Reports First Quarter 2024 Financial Results | NASDAQ:HSDT | Helius Medical Technologies Inc |
| 2024/05/10 | 22 : 00 | GlobeNewswire Inc. | Helius Medical Technologies, Inc. to Release First Quarter 2024 Financial Results on May 13, 2024 | NASDAQ:HSDT | Helius Medical Technologies Inc |
| 2024/05/10 | 05 : 31 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:HSDT | Helius Medical Technologies Inc |
| 2024/05/09 | 05 : 56 | Edgar (US Regulatory) | Form 424B4 - Prospectus [Rule 424(b)(4)] | NASDAQ:HSDT | Helius Medical Technologies Inc |
| 2024/05/07 | 11 : 15 | GlobeNewswire Inc. | Helius Medical Technologies, Inc. Announces Pricing of $6.4 Million Public Offering | NASDAQ:HSDT | Helius Medical Technologies Inc |